Trial Profile
Clinical efficacy of apatinib in treating locally advanced cervical cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 31 Jul 2018 New trial record